MEDY-TOX INC. revenue breakdown overview

MEDY-TOX INC. revenue for the last year amounted to 228.60 B KRW, the most of which — 224.77 B KRW — came from its highest performing source at the moment, Biopharmaceutical Products, the year earlier bringing 217.16 B KRW. The greatest contribution to the revenue figure was made by South Korea — last year it brought MEDY-TOX INC. 84.21 B KRW, and the year before that — 79.82 B KRW.